1
Open
[.]
2
Close
[.]
3
Allotment
—
4
Listing
[.]
Issue Size
[.] shares (agg. up to ₹740 Cr)
Listing Date
[.]
✦ AI Insight
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 952.48 | 696.69 | 601.76 |
| Total Income | 816.52 | 769.45 | 650.65 |
| Profit After Tax | 78.71 | 73.68 | 43.09 |
| EBITDA | 144.24 | 139.18 | 90.91 |
| NET Worth | 456.62 | 275.31 | 209.71 |
| Reserves and Surplus | 415.87 | 238.44 | 197.96 |
| Total Borrowing | 282.23 | 264.35 | 240.85 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Symbiotec Pharmalab Ltd. | Mainboard | ₹1,757.00 Cr | ₹988 | 55.44 | ₹1,097.70 | +11.10% | ₹1,133.45 |
| Hexagon Nutrition Ltd. | Mainboard | ₹138.87 Cr | ₹45 | 22.69 | ₹53.19 | +18.20% | ₹67.99 |
| Sai Parenteral's Ltd. | Mainboard | ₹408.79 Cr | ₹392 | 72.19 | ₹405.70 | +3.49% | ₹523.35 |
| Corona Remedies Ltd. | Mainboard | ₹655.37 Cr | ₹1062 | 43.47 | ₹1,438.40 | +35.44% | ₹2,236.10 |
| Rubicon Research Ltd. | Mainboard | ₹1,377.50 Cr | ₹485 | 55.75 | ₹628.20 | +29.53% | ₹1,835.40 |
| Bio Medica Laboratories Ltd. | SME | ₹52.43 Cr | ₹139 | 13.03 | ₹115.80 | -16.69% | ₹158.00 |
| Goldline Pharmaceutical Ltd. | SME | ₹11.61 Cr | ₹43 | 10.47 | ₹56.77 | +32.02% | ₹36.50 |
| Speciality Medicines Ltd. | SME | ₹29.14 Cr | ₹124 | 9.27 | ₹125.90 | +1.53% | ₹166.00 |
| Accretion Nutraveda Ltd. | SME | ₹24.77 Cr | ₹129 | 26.27 | ₹191.20 | +48.22% | ₹270.00 |
| KRM Ayurveda Ltd. | SME | ₹77.49 Cr | ₹135 | 17.32 | ₹180.70 | +33.85% | ₹307.70 |
| Curis Lifesciences Ltd. | SME | ₹27.52 Cr | ₹128 | 12.44 | ₹141.00 | +10.16% | ₹198.35 |
| Aptus Pharma Ltd. | SME | ₹13.02 Cr | ₹70 | 11.29 | ₹84.84 | +21.20% | ₹339.90 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding capital expenditure requirement for capacity expansion at the Expansion Units | 360.00 |
| 2 | Prepayment of all or a portion of certain outstanding borrowings availed by our Company | 195.00 |
| 3 | General corporate purposes |
About Virupaksha Organics IPO
Updated on Feb 13, 2026
Contact Details
Virupaksha Organics Ltd. AddressPlot No. B1 & B2, IDA Gandhinagar,Kukatpally, Medchal, MalkajgiriHyderabad, Telangana, 500037+ 91 4023075816cs@virupaksha.comVisit Website